Multifunctional Albumin Nanoparticles As Combination Drug Carriers for Intra-Tumoral Chemotherapy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multifunctional Albumin Nanoparticles As Combination Drug Carriers for Intra-Tumoral Chemotherapy
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume 2, Issue 9, Pages 1236-1245
Publisher
Wiley
Online
2013-03-14
DOI
10.1002/adhm.201200467
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SPARC Expression Correlates with Tumor Response to Albumin-Bound Paclitaxel in Head and Neck Cancer Patients
- (2014) Neil Desai et al. Translational Oncology
- Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate
- (2010) Yun W. Alelyunas et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Nanoparticle albumin-bound (nab™)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer
- (2010) Javier Cortes et al. EJC SUPPLEMENTS
- Targeting of drugs and nanoparticles to tumors
- (2010) Erkki Ruoslahti et al. JOURNAL OF CELL BIOLOGY
- Delivering nanomedicine to solid tumors
- (2010) Rakesh K. Jain et al. Nature Reviews Clinical Oncology
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Albumin Nanoshell Encapsulation of Near-Infrared-Excitable Rare-Earth Nanoparticles Enhances Biocompatibility and Enables Targeted Cell Imaging
- (2010) Dominik J. Naczynski et al. Small
- Combinatorial Drug Conjugation Enables Nanoparticle Dual-Drug Delivery
- (2010) Santosh Aryal et al. Small
- Is Anticancer Drug Development Heading in the Right Direction?
- (2009) Trevor W. Hambley CANCER RESEARCH
- A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma
- (2009) D. Yip et al. CLINICAL CANCER RESEARCH
- AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1)
- (2009) Seung-Shick Shin et al. Pigment Cell & Melanoma Research
- Protein nanoparticles as drug carriers in clinical medicine
- (2008) Michael J. Hawkins et al. ADVANCED DRUG DELIVERY REVIEWS
- Specific Targeting of HER2 Overexpressing Breast Cancer Cells with Doxorubicin-Loaded Trastuzumab-Modified Human Serum Albumin Nanoparticles
- (2008) Marion G. Anhorn et al. BIOCONJUGATE CHEMISTRY
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy
- (2008) Kyung Hyun Min et al. JOURNAL OF CONTROLLED RELEASE
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds
- (2008) Elaine M. Merisko-Liversidge et al. TOXICOLOGIC PATHOLOGY
- Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
- (2008) Bharat B. Aggarwal et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started